Dofetilide

Authors:

Abstract
Dofetilide is a new antiarrhythmic drug that recently was recommended for approval by an advisory committee to the Food and Drug Administration (FDA) for treatment of patients with persistent atrial fibrillation. Dofetilide is a specific blocker of the rapid component of the outward delayed rectifier potassium current I Kr and will represent the first drug with relatively pure class III antiarrhythmic properties to be widely released. Cardiac depolarization results principally from the flow of inward Na+ and Ca2+ ions as the rapid and slow inward currents. Repolarization results from a balance between inactivation of the slow inward current and activation of repolarizing predominantly K+ currents. Early repolarization results from a transient outward current, I TO, which is activated rapidly by membrane depolarization. Terminal repolarization is mediated by outward delayed rectifier K+ currents, I K, which are activated slowly (over a period of 200 to 300 ms) on membrane depolarization and turn off, or deactivate, relatively slowly on membrane repolarization. I K can be separated pharmacologically into 2 components: a rapidly activating component, I Kr, and a slower component, I Ks, each carried by a separate ion channel molecule.1 2 HERG channels are responsible for I Kr, whereas I Ks flows through KvLQT1 channels. Specific blockers of I Kr are therefore classified as pure class III antiarrhythmic agents because they produce only prolongation of action potential duration (and hence of QT interval). These actions may result in arrhythmia termination or suppression but can also lead to excess QT prolongation and polymorphic ventricular tachycardia. Examples of specific I Kr blockers include the methanesulfonanilide agents dofetilide, E4031, almokalant, and d-sotalol. ### Effects of Dofetilide on I kr Dofetilide blocks I Kr in all myocardial tissues with high potency (50% effective concentration [EC50] in the nanomolar range). Block …

This publication has 51 references indexed in Scilit: